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Maintenance of adequate renal function after living kidney donation is important for donor 
outcome. Overweight donors in particular may have an increased risk for end stage kidney 
disease (ESKD), and young female donors have an increased preeclampsia risk. Both of 
these risks may associate with low post-donation renal functional reserve (RFR). Because 
we previously found that higher BMI and lower post-donation RFR were associated, we now 
studied the relationship between BMI and RFR in young female donors. RFR, the rise in GFR 
(125I-Iothalamate clearance) during dopamine, was measured in female donors (<45 years) 
before and after kidney donation. Donors who are overweight (BMI>25) and non-overweight 
donors were compared by t-test; the association was subsequently explored with regression 
analysis. We included 105 female donors (age 41 [36-44] (median[IQR])) with a BMI of 25 
[22-27] kg/m2. Pre-donation GFR was 118 (17) ml/min (mean(SD)) rising to 128 (19) ml/min 
during dopamine; mean RFR was 10 (10) ml/min. Post-donation GFR was 76 (13) ml/min, 
rising to 80 (12); RFR was 4 (6) ml/min (p<0.001 vs. pre-donation). In overweight donors, 
RFR was fully lost after donation (1 ml/min vs. 10 ml/min pre-donation, p<0.001), and BMI 
was inversely associated with RFR after donation, independent of confounders (St. β 0.37, 
p=0.02). Reduced RFR might associate with the risk of preeclampsia and ESKD in kidney 
donors. Prospective studies should explore whether RFR is related to preeclampsia and 
whether BMI reduction prior to conception is of benefit to overweight female kidney donors 
during and after pregnancy.




Living donor kidney transplantation is the preferred treatment for patients with end-
stage kidney disease (ESKD), providing better outcomes compared to either dialysis or 
transplantation of a kidney from a deceased donor(25). Although efficient living donor 
programs have been established, a shortage of donor organs still exists, which has led 
to liberalization of selection criteria for the living donor(29). Nowadays, donors with a high 
body mass index (BMI) are more often eligible for donation, leading to an increased number 
of obese donors(24). However, donors may have an increased risk for ESKD, in particular 
when they are obese(23).
After kidney donation, vasodilation occurs in the remaining kidney as a compensatory 
response to maintain glomerular filtration rate (GFR) (21); as a logical consequence, the 
vasodilatory reserve capacity decreases(31, 39, 41). In 2008, Rook et al. showed that in 
living kidney donors, a higher donor BMI was associated with loss of renal functional reserve 
(RFR). This was assessed as the dopamine response, also known as reserve capacity(32). 
RFR was fully lost in older donors with BMI > 30 kg/m2, while they maintained an adequate 
GFR in the short term. However, the implication of loss of RFR for long-term outcomes in 
obese donors has not yet been established.
Obesity is also a major risk factor for preeclampsia (PE). Of note, Garg et al. reported a 
significantly increased risk to develop gestational hypertension or preeclampsia (PE) (15), 
extending earlier survey data (18, 30). During normal pregnancy renal blood flow and GFR 
increase during the first half of pregnancy (8, 19, 22). Absence of pregnancy-induced renal 
vasodilation and absence of the hyperfiltration of pregnancy are hallmarks of PE (8, 12,28). 
A low RFR in young female donors, as a possible indicator of reduced renal vasodilator 
capacity, may therefore be relevant to the findings by Garg et al. and others on PE risk (15, 
18, 30).
Due to the low number of young female kidney donors included in the 2008 study, Rook et 
al. mainly found an effect in older donors and were unable to draw conclusions on either loss 
or preservation of RFR in women of childbearing age (32). We hypothesized that renal RFR 
is lost in overweight young female donors after donation. In the current study, therefore, we 
studied the relationship between BMI and renal RFR by dopamine response before and 




We performed a retrospective cohort study, consisting of 105 living female kidney donors 
between 18 and 45 years old, who donated between 1992 and 2016 at the University 
Medical Center Groningen. Data was collected from the living donors screening and follow-
up program in our center, at four months before and two months after donation. The study 
was approved by the institutional review board (METc 2014/077) and was conducted in 
accordance with the declaration of Helsinki.
Renal function measurements
Kidney function was measured using 125I-Iothalamate and 131I-hippurate infusion as 
described (32): Measurements were performed in a quiet room, with the subject in semi-
supine position. After drawing a blood sample, 125I-Iothalamate and 131I-hippurate infusions 
were given (0.04 mL/kg containing 0.04 MBq and 0.03 MBq respectively). At 08.00 hour 0.6 
MBq of 125I-Iothalamate was administered, followed by continuous infusion of 12 mL/h. After 
a two-hour stabilization period, baseline measurements started in a steady state of plasma 
tracer levels. Clearances were calculated as (U*V)/P and (I*V)/P, where U*V represents the 
urinary excretion, I*V represents the infusion rate of the tracer and P represents the plasma 
tracer concentration per clearance period. From clearance levels of these tracers, GFR, 
effective renal plasma flow (ERPF) and filtration fraction (FF) were calculated. Correction 
for incomplete bladder emptying and dead space was achieved by multiplying the urinary 
125I-Iothalamate clearances with plasma and urinary 131I-hippurate clearance. Day-to-day 
variability of GFR is 2.5% (1).
Renal functional reserve (RFR), expressed as the change in GFR in ml/min, was measured 
by extending the above-mentioned procedure by two hours with a dopamine infusion of 1.5 
µg/kg/min (38).
Clinical and biochemical measurements
At both time points, height, weight and blood pressure measurements were collected. 
Conforming to selection criteria of our kidney donor program, all donors were normotensive 
or had adequately regulated blood pressure with a maximum of one antihypertensive drug. 
Use of anti-hypertensives was very low (3%); adjustment of the analysis for use of anti-
hypertensives did not change the conclusions, and is therefore not included in this paper. 
Furthermore, subjects with a history of diabetes (or an abnormal glucose tolerance test), 
kidney disease or cardiovascular events were excluded from kidney donation. Use of 
contraceptives (9%) was underreported and not included in our analysis. BMI was calculated 
as (body weight/height2), where a BMI ≥25 kg/m2 was considered as being overweight. 
Proteinuria (g/24h) was measured from 24-hour urine collection by a standard assay.




Data are reported as mean (standard deviation, SD) for normally distributed variables and 
median [interquartile range, IQR] for skewed data. Binary variables are shown as “number 
(%)”. GFR data are reported as absolute values (mL/min) and normalized for body surface 
area (BSA; mL/min/1.73m2) as well as height (mL/min/m). This was done because BSA 
and BMI are strongly correlated. Accordingly, BSA-adjustment, although customary in the 
literature, induces a systematic error in analyses for possible associations with BMI(10). 
In line with prior papers(4) we therefore report height-normalized values along with BSA-
normalized values. RFR is reported as change in GFR in mL/min during dopamine infusion. 
A t-test was used to determine differences between normal and overweight kidney donors, 
after transformation of skewed data. If data remained skewed after transformation, a 
Mann-Whitney U test was performed. To investigate association between BMI and RFR 
after donation, linear regression analysis was performed with BMI as independent and 
difference in RFR as dependent variable. We adjusted for potential confounders (GFR, age) 
in subsequent multivariable analysis. Statistical analyses were performed by SPSS version 
22 for Windows (IBM, Armonk, NY) and Graphpad Prism 6 for Windows (Graphpad, San 
Diego, CA). P-values of <0.05 were considered statistically significant.
Results
Pre- and post-donation characteristics
We included 105 female living kidney donors who were 41 [36-44] years old at donation, 
with a BMI of 25 [22-27] kg/m2. Before donation, the GFR was 118 (17) mL/min, rising to 128 
(19) mL/min during dopamine. The ERPF was 405 (74) mL/min, rising to 496 (113) mL/min 
during dopamine. Pre-donation characteristics are shown in table 1 by a break-up of BMI at 
25 kg/m2. A higher BMI was associated with elevated GFR, both when expressed nominally 
and after normalization to height, indicating overweight-associated “hyperfiltration” (figure 
1A and 1B). The RFR was 10 (10) mL/min, with no difference between the BMI categories. 
At 2 months after donation (57 [50-63] days; table 2), mean GFR was 76 (13) mL/min rising 
to 80 (12) during dopamine. The break-up by BMI shows that nominal and height-adjusted 
GFR were significantly higher in overweight donors (figure 1C and 1D). ERPF was 286 (49) 
mL/min, rising to 332 (65) mL/min during dopamine. Post-donation RFR was 4 (6) mL/min, 
with a remarkable difference between the BMI categories. In the donors with a BMI <25 kg/
m2 RFR was 6 (5) mL/min, whereas in donors with a BMI ≥ 25 kg/m2 RFR was completely 
lost (1 (7) mL/min, p=0.002 vs. BMI <25 kg/m2). The absolute change in RFR from pre- to 
post-donation was significantly different between BMI groups (low BMI -4 (7) mL/min, vs. 
high BMI -8 (6) mL/min, p=0.01). 
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Table 1. Pre-donation donor characteristics
Variable All donors BMI <25 (n=54) BMI ≥25 (n=51) P
Age (years) 41 [36-44] 41 [38-44] 41]  [36-44 0.37
Systolic blood pressure (mmHg) 120 (10) 118 (9) 121 (11) 0.09
Diastolic blood pressure (mmHg) 74 (8) 73 (8) 74 (8) 0.37
Use of antihypertensives, n (%) 2 (2%) 0 (0%) 2 (4%) 0.18
Weight (kilogram) 71 [63-82] 63 [59-68] 82 [77-85] <0.001
GFR absolute (mL/min) 118 (17) 112 (13) 125 (18) <0.001
GFR normalized for height* (mL/min/m) 70 (10) 66 (7) 73 (10) <0.001
GFR per kidney† (mL/min) 59 (8) 56 (6) 63 (9) <0.001
GFR during dopamine (mL/min) 128 (19) 122 (17) 135 (19) 0.001
GFR during dopamine per kidney† (mL/
min)
64 (10) 61  (9) 68 (9) 0.001
GFR during dopamine normalized for 
height1 (mL/min/m)
35 (5) 33 (4) 37 (5) 0.001
GFR during dopamine per kidney† per 
height* (mL/min/m)
38 (6) 36 (5) 40 (6) 0.001
Renal functional reserve (mL/min)
















ERPF (mL/min) 405 (74) 393 (70) 417 (78) 0.18
ERPF normalized for BSA (mL/
min/1.73)
389 (76) 402 (79) 377 (71) 0.10
ERPF normalized for height (mL/min/m) 242 (45) 236 (45) 248 (45) 0.19
ERPF during dopamine (mL/min) 496 (113) 484 (107) 509 (118) 0.28
Filtration fraction (proportion) 0.30 (0.05) 0.29 (0.05) 0.30 (0.05) 0.14
Proteinuria (g/24h) 0.0 [0.0-0.2] 0.0 [0.0-0.2] 0.0 [0.0-0.2] 0.72
Albuminuria (mg/L) 1.3 [0.0-2.9] 1.0 [0.0-2.1] 1.5 [0.0-2.9] 0.61
GFR, Glomerular Filtration Rate (125I-Iothalamate); ERPF, Effective Renal Plasma Flow (131I-hippurate)
* calculated as GFR / height (meters)
†
 calculated as absolute GFR / 2
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Table 2. Post-donation donor characteristics 
Variable All donors BMI <25 (n=54) BMI ≥25 (n=51) P
Systolic blood pressure (mmHg) 118 (11) 115 (11) 121 (11) 0.01
Diastolic blood pressure (mmHg) 73 (7) 73 (8) 74 (7) 0.30
Use of antihypertensives, n (%) 2) (2%) 0 (0%) 2 (4%) 0.18
Weight (kilogram) 70 [63-81] 63 [58-69] 81 [76-86] <0.001
GFR absolute (mL/min) 76 (13) 70 (9) 82 (13) <0.001
GFR normalized for height* (mL/min/m) 45 (7) 42 (5) 48 (8) <0.001
GFR during dopamine (mL/min) 80 (12) 76 (10) 84 (13) 0.002
GFR during dopamine normalized for 
height* (mL/min/m)
47 (7) 45 (6) 49 (7) 0.005
Renal functional reserve (mL/min) 4 (6) 6 (5) 1 (7) 0.002
Renal functional reserve change† (mL/
min)
-1 (7) 1 (7) -4 (6) 0.003
ERPF (mL/min) 286 (49) 270 (45) 300 (49) 0.04
ERPF normalized for BSA (mL/min/1.73) 271 (47) 271 (48) 270 (47) 0.93
ERPF normalized for height (mL/min/m) 242 (45) 236 (45) 248 (45) 0.02
ERPF during dopamine (mL/min) 322 (65) 311 (63) 333 (67) 0.11
Filtration fraction (proportion) 0.28 (0.04) 0.27 (0.04) 0.29 (0.04) 0.14
Proteinuria (g/24h) 0.0 [0.0-0.2] 0.0 [0.0-0.1] 0.1 [0.0-0.2] 0.28
Albuminuria (mg/L) 2.3 [0.8-3.0] 2.3 [1.0-3.0] 2.3 [0.5-3.0] 0.57
GFR, Glomerular Filtration Rate (125I-Iothalamate); ERPF, Effective Renal Plasma Flow (131I-hippurate)
* calculated as GFR / height (meters)
†
 calculated as post-donation RFR – pre-donation RFR per kidney 
Association between BMI and renal hemodynamics
BMI was positively associated with GFR, both before (st. β 0.31, p=0.001) and after donation 
(st. β 0.36, p<0.001). BMI was inversely associated with post-donation RFR (st. β -0.32, 
p=0.003), but not with pre-donation RFR (st. β 0.07, p=0.49). The association between 
BMI and post-donation RFR was independent of donor GFR, age and blood pressure (st. 
β -0.33, p=0.004, table 3). When excluding donors with a BMI over 35 (n=2), the results of 
model remained materially similar (st. β -0.36, p=0.003). There was no effect modification by 
age (pinteraction=0.62). Furthermore, BMI was inversely associated with the absolute change in 
RFR before vs. after donation (st. β -0.24, p=0.02).
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Table 3. Linear regression analysis of BMI and change in renal functional reserve




Systolic blood pressure  0.20 0.12
Diastolic blood pressure  0.03 0.81
GFR  -0.09 0.42
BMI -0.33 0.004
BMI, Body Mass Index (kg/m2); GFR, Glomerular Filtration Rate (125I-Iothalamate)
Model 1: donor BMI at donation
Model 2: model 1 plus donor characteristics



























































































Figure 1. GFR before and during dopamine in donors grouped according to BMI
(A) Pre-donation GFR. (B) Pre-donation GFR normalized for height. (C) Post-donation GFR (D) Post-
donation GFR normalized for height. Donors with a BMI ≥ 25 kg/m2 post-donation did not show a 
significant rise in GFR during dopamine (p=0.19).




In this study, we observed that BMI is inversely associated with RFR, measured by dopamine 
infusion, after kidney donation in women of childbearing age. Moreover, RFR was fully lost 
in overweight women after donation, suggesting that in the female kidney donor with a high 
BMI, RFR is consumed after kidney donation.
After kidney donation, vasodilatation occurs as a compensatory response to adapt to the 
single-kidney state(39). This results in a single-kidney GFR of approximately 66% of the 
prior two-kidney state, instead of approximately 50%(36). In this cohort of female donors of 
childbearing age we found a similar hemodynamic response (post-donation GFR was 64% 
of pre-donation GFR). Based on our results, we hypothesize that hyperfiltration due to the 
combination of overweight and donation prevents further increase in GFR in response to 
dopamine(3, 35).
Being overweight is associated with distinct renal hemodynamic effects, i.e. a rise in ERPF 
and a relatively greater rise in GFR. This results in a rise of filtration fraction (4), in particular 
when associated with a central fat distribution(20). These associations are also present in 
single kidneys, i.e. after donation (current data) and in transplanted kidneys(5). Only in the 
single kidney state is a negative association of BMI with the GFR response to dopamine 
observed. Recently it was shown that the higher GFR in overweight patients is associated 
with a higher single-nephron GFR. Additionally, this is associated with larger glomeruli, and 
with more glomerulosclerosis and arteriolosclerosis than expected for age(11). The latter 
supports the assumption that an elevated single nephron GFR contributes to glomerular 
injury(17). Unfortunately, data on single nephron GFR and RFR in single kidneys are lacking 
so far. 
Prompted by the report on increased PE risk post-donation (15), we focused on women of 
childbearing age. Absence of pregnancy-induced renal vasodilation is a hallmark of PE(8, 
12,25). Our data raise the hypothesis that loss of renal vasodilator capacity, as reflected by 
loss of RFR after donation in overweight women, could be involved in the increased risk 
for PE after donation. This hypothesis is also strengthened by the fact that obesity is an 
important risk factor for PE (42). Unfortunately, Garg et al do not report BMI and accordingly, 
it is unknown from their study, whether the donors with PE were overweight(15). Other 
possible factors in the increased risk of PE after donation include the loss of GFR, direct 
effects of obesity on placental development(34) or effects of high blood pressure(6). In 




Our results are in line with previous studies showing that higher BMI is associated with 
more RFR loss post-donation in female and male donors(26, 32). Dopamine, a prominent 
vasodilator, was used to induce renal vasodilatation and hence estimate RFR. In line with 
prior studies RFR is thus assessed as the acute hemodynamic response to a pharmacological 
trigger(40). Dopamine is an endogenous catecholamine that acts on dopaminergic receptors, 
which are also present in the kidney(12). It thus elicits dilatation of arterioles, both afferent 
but predominantly efferent, resulting in a rise of renal blood flow and GFR(39). Because of 
safety concerns and cardiovascular effects of dopamine infusions, a low-dose is used for 
testing RFR. The renal hemodynamic response therefore does not reflect the maximum 
vasodilator capacity, which likely reduces the sensitivity of RFR to detect subtle changes 
in glomerular hemodynamics and microvasculature. Thus, we speculate that absence of 
an association between BMI and RFR before donation may be due to lack of sensitivity 
of RFR. Alternatively, differential effects of being overweight and dopamine on afferent-
efferent vasomotor balance before and after donor nephrectomy may have been involved.
What could be the implications of a reduced RFR? The concept of RFR originates from the 
1980’s, starting from the notion that nephron loss generally does not lead to a corresponding 
loss in GFR, as is readily apparent after kidney donation, indicating that the kidney has 
some form of functional reserve(27, 37). The hypothesis was that loss of reserve capacity 
might better indicate the extent of nephron loss than GFR and accordingly, that loss of 
RFR might be a useful prognostic parameter for future renal function(40). However, this 
hypothesis has not been substantiated, due to a general paucity of data on sufficiently 
powered cohorts where both RFR and long term follow-up are available. Cross-sectional 
studies found RFR to be inversely associated with old age(14) and advancing stages of 
CKD (2). The short-term prognostic effects of RFR after donation have been reported by our 
group (33), showing that pre-donation RFR has a modest predicting effect for GFR shortly- 
after donation(33). Work on long term follow-up is still in progress.
The main limitation of our paper is the lack of long-term renal data and lack of data on 
pregnancy outcomes of living kidney donors. Also, the predictive effect of BMI is subtle and 
we have insufficient data to adjust for use of contraceptives or menstrual cycle period, which 
both influence renal hemodynamics(7). However, the effect of BMI on RFR is consistent in 
donors with only mild overweight (we included only two donors with a BMI over 35). Our 
study does not have sufficient power to show effects of BMI on ERPF reserve capacity, 
which can be relevant since the exact mechanism of “hyperfiltration” after donation is not 
yet clarified and may be dependent on glomerular hypertrophy(21). 
Strong points of our study include state-of-the-art renal hemodynamics measurements, with 
continuous 125I-Iothalamate and 131I-hippurate infusions, instead of per-bolus administration. 
Our study links a modifiable risk factor, namely overweight, to RFR in young kidney donors. 
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Further studies are needed to study the effect of weight interventions on RFR in overweight 
women of childbearing age. 
In conclusion, this study shows that overweight women of childbearing age have a diminished 
RFR after kidney donation. Long-term studies should substantiate the role of reduced RFR 
on long-term renal outcome and PE. Since the incidence of overweight amongst donors is 
rising, and BMI is an independent risk factor for ESKD(16, 23), a clear understanding of 
the impact of lifestyle on living donation is warranted. Prospective studies should explore 
whether BMI reduction prior to conception is of benefit to overweight female kidney donors 
during and after pregnancy.
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